Skip to main content

Market Overview

Bio-Techne Announces ISO 14001:2015 Certification for the EMEA region of Bio-Techne.

Share:

MINNEAPOLIS, Feb. 25, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH), a leading provider of proteins, antibodies and cytokines today announced that its sites in Abingdon, Langley, Rennes and Wiesbaden received ISO 14001:2015 certification for Environmental Management Systems. These Bio-Techne facilities provide Sales, Marketing, Purchasing, Order Processing, Warehousing, Distribution and Customer Services for the EMEA region.

ISO 14001 is an internationally recognized standard intended to provide a framework for companies to protect the environment and respond to changing environmental conditions. This achievement provides assurances to our customers that Bio-Techne is striving to contribute to the environmental pillar of sustainability.

"The EMEA team worked hard to become ISO 14001:2015 compliant and the certification is quite an achievement," said Dave Eansor, President Protein Sciences. "This certification reflects Bio-Techne's focus on minimizing its environmental impacts and I am very pleased with the team."

"I am proud of the EMEA team on this important accomplishment," said Kim Kelderman, President Genomics and Diagnostics. "Achieving ISO:14001:2015 compliance shows Bio-Techne's dedication to ongoing enhancement of our environmental performance."

"Environmental management is an integral core value and a vital part of Bio-Techne's culture," commented Chuck Kummeth, President and Chief Executive Officer of Bio-Techne.  "This achievement is another milestone in our continuous drive toward sustainability."

About Bio-Techne Corporation (NASDAQ:TECH)

Contact:

David Clair, Senior Director, Corporate Development


david.clair@bio-techne.com


612-656-4416

 

Bio-Techne

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-announces-iso-140012015-certification-for-the-emea-region-of-bio-techne-301235378.html

SOURCE Bio-Techne Corporation

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com